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Abstract: Purpose: It is aimed to evaluate the technical feasibility, safety, outcome, and incidence of complications after 
clear corneal phacoemulsification with foldable intraocular lens implantation (IOL) and triamcinolone assisted pars plana 
vitrectomy in patients with proliferative diabetic retinopathy. 
Methods: The results of combined phacoemulsification, in the capsular bag foldable intraocular lens implantation and 
triamcinolone assisted pars plana vitrectomy in 75 eyes of 72 patients, were retrospectively evaluated. Surgery was per-
formed using general anesthesia in 9 cases, and monitored retrobulbar block in 66 cases. In all cases, phacoemulsification 
with clear corneal incision and foldable acrylic IOL implantation were performed before vitreoretinal surgery. The main 
investigation points were preoperative and postoperative best corrected visual acuity (BCVA), and intraoperative and 
postoperative complications. 
Results: The mean age at surgery was 62.07 ± 9.51 years (range 22 to 78 years) and the postoperative follow-up time was 
17.17 ± 7.25 months. All eyes had clinically significant cataract that interfered with visualization of the retina preopera-
tively. All eyes had proliferative diabetic retinopathy. Postoperatively, visual acuity improved in 65 eyes (86.7%), was 
unchanged in 9 eyes (12.0%), and decreased in 1 eye (1.3%). The most postoperative complications consisted of a mild ir-
itis in 8 eyes (10.7%), recurrent vitreous hemorrhage in 8 eyes (10.7%), posterior capsule opacification in 7 eyes (9.3%), 
transient intraocular pressure increase in 6 (8.0%), iatrogenic retinal tear in 6 (8.0%), epiretinal membrane in 5 (6.7%). 
Conclusion: The results of combined phacoemulsification in the capsular bag foldable IOL implantation and triamci-
nolone assisted pars plana vitrectomy show that visual acuity outcomes are generally favorable and complications are ac-
ceptable in diabetic patients. Visual results and complications depend primarily on the underlying posterior segment pa-
thology. The use of triamcinolone acetonide may simplify surgery and decreases the postoperative inflammation. 
Keywords: Phacoemulsification, triamcinolone assisted vitrectomy, intraocular lens implantation, proliferative diabetic reti-
nopathy. 
INTRODUCTION 
  Cataract often coexists with pathologies at the vitreous 
body. Even if cataract is not significant at the time of vitrec-
tomy, it can progress postoperatively. After pars plana 
vitrectomy (PPV), cataract development is common (75%). 
Several authors report difficulties in performing cataract 
extraction after vitrectomy because of insufficient vitreous 
support. Lens opacities interfere with appropriate visualiza-
tion of the vitreous chamber and the eye fundus, which 
makes performing vitreoretinal procedure difficult. These 
difficulties led to the idea of performing cataract extraction 
at the time of vitrectomy. For this reason, in such patients, a 
combined procedure of PPV and cataract extraction can be 
considered. The results of combined surgery have been re-
ported many times; however, the results are controversial [1-
4]. 
  During PPV it is essential to visualize the residual vitre-
ous cortex and posterior hyaloid. Triamcinolone acetonide 
(TA) is a water-insoluble steroid and has strong anti-
inflamatory  and  antiangiogenic  activity   [5,6].  Intravitreal  
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injection of TA during PPV appeared to aid visualization of 
the vitreous and posterior hyaloid. 
  In this study, we aimed to evaluate the technical feasibil-
ity, safety, outcome, and incidence of complications after 
clear corneal phacoemulsification with foldable intraocular 
lens implantation and triamcinolone-assisted pars plana 
vitrectomy in the patients with proliferative diabetic patients. 
MATERIALS AND METHODS 
  The results of combined phacoemulsification, in the cap-
sular bag foldable IOL implantation and triamcinolone as-
sisted pars plana vitrectomy in 75 eyes of 72 patients, were 
retrospectively evaluated. All patients had clinically signifi-
cant lens opacities and vitreoretinal pathology requiring pars 
plana vitrectomy. Patients had surgery by the same surgeon 
(H.B.) at the department of Ophthalmology, University of 
Ondokuz May s, between May 2004 and July 2007. 
  All eyes had proliferative diabetic retinopathy. Typical 
indications for vitrectomy are recurrent or non-clearing vit-
reous hemorrhage, tractional retinal detachment and trac-
tional macular edema. The cases of combined tractional-
rhegmatogenous retinal detachment were excluded. Preop-
erative clinical data included the patient’s age, sex, underly-
ing vitreous or retinal disease, and preoperative visual acuity. 
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graphic evaluation and intraocular lens calculation were per-
formed in the eye before surgery. If this not possible, the 
data were taken from the fellow eye. Intraocular lens calcula-
tion was performed using the Binkhorst formula. 
  Preoperatively, pupils were dilated with drops 1% cy-
clopentolate hydrochloride, 0.03% flurbiprofen, and 1% 
tropicamide, three times, 1drop every 10 minutes. Surgery 
was performed using general endotracheal anesthesia in 9 
cases, and monitored retrobulbar block in 66 cases. 
  The cataract was extracted firstly. A 3.2 mm wide and 
1.5 to mm long clear corneal tunnel was created at the supe-
rior limbus. A 5.0 to 6.0 mm curvilinear capsulorhexis was 
completed, Bimanual phacoemulsification and cortex re-
moval were performed. The anterior chamber and capsular 
bag were filled with sodium hyaluronate (Healon GV) and a 
foldable acrylic IOL (Sensar AR40
®, Allergan Surgical)) 
was inserted into the capsular bag. The visco-elastic material 
was then removed by irrigation/aspiration. The incision was 
closed with a single 10-0 nylon suture before vitrectomy. 
  A standard 3-port pars plana vitrectomy was performed 
using a 20 gauge vitreous cutter and handheld light pipe un-
der a noncontact wide-angle viewing system (BIOM, Ocu-
lus). Sclerotomies were placed 3.5 mm posterior to the lim-
bus in to superotemporal, superonasal, and inferotemporal 
quadrants. The infusion cannula was sutured in the infero-
temporal sclerotomy site. After core vitrectomy, 0.1-0.2 ml 
triamsinolone acetonide suspension was injected mid-
vitreous cavity. The triamcinolone granules were trapped in 
the gel structure of the residual vitreous cortex. After this 
procedure, residual vitreous cortex was typically seen on the 
retina as either diffuse membrane or small islands. These 
vitreous islands were there-after removed by surgical forceps 
or a silicon-tipped needle. Intraocular scissors, forceps, and 
picks were necessarily used to elevate and section membrane 
if areas of significant preretinal proliferation were encoun-
tered. Hemostasis was obtained with the use of the diathermy 
of the tissue manipulator. After posterior hyaloid separation 
and removal of residual vitreous cortex, the resection of fi-
brous tissue and endolaser photocoagulation were performed 
when needed. Thereafter, we attempted to wash out the re-
sidual triamcinolone granules. Fluid/air exchange was per-
formed in 9 eyes (12.0%), silicone oil tamponade in 6 eyes 
(8.0%), and 20% sulphur hexafluoride (SF6) tamponade in 2 
eyes (2.7%). As a last step in the operation, 0.1 ml (4 mg) 
triamsinolone acetonide was injected into the vitreous cavity 
of the patients without any tamponade. Sclerotomies and 
conjunctiva were sutured, and subconjunctival gentamicin 
sulfate (20 mg) and dexamethasone sodium phosphate (4 
mg) were administered. 
  Postoperative data included Snellen visual acuity, opera-
tive and postoperative complications, intraocular pressure, 
anterior and posterior segment evaluations. Patients were 
controlled postoperative first week, first month, and every 
two months. Major outcomes were preoperative and postop-
erative best corrected visual acuity. Visual improvement was 
defined as an increase of more than 2 lines on the Snellen 
acuity chart. Changes from hand movements to counting 
fingers and from counting fingers to 0.1 were also consid-
ered visual improvement. 
 
RESULTS 
  The study sample included 75 eyes of 72 patients, 42 
women and 29 men. The mean age at surgery was 62.07 ± 
9.51 years (range 22 to 78 years) and the postoperative fol-
low-up time 17.17 ± 7.25 months (range 3 to 39 months). All 
eyes had clinically significant cataract that interfere with 
visualization of the retina preoperatively. 
  All corneas remained clear during cataract surgery and 
pars plana vitrectomy, and throughout the postoperative pe-
riod. The posterior capsule remained intact in each case and 
intraocular lenses were implanted in the capsular bag in all 
cases. Adjunctive vitreoretinal surgery included argon laser 
photocoagulation, epiretinal membrane peeling, internal 
limitan membrane peeling, air-fluid exchange in required 
cases. 
  This study showed an important improvement in visual 
acuity (Fig. 1). That is, postoperatively, visual acuity im-
proved in 65 eyes (86.7%), unchanged in 9 eyes (12.0%), 
and decreased in 1 eye (1.3%). Table 1 describes the best 
corrected visual acuity outcomes. 
 
Fig. (1). Preoperative and final postoperative visual acuities in the 
combined surgery. 
 
Table 1.  Distribution of Best Corrected Visual Acuity 
 
Best Corrected Visual Acuity  Preoperative  Postoperative 
0.5 -  15  (20.0%) 
0.1-0.4  6 (8.0%)  38 (50.6%) 
Counting fingers  22 (29.3%)  17 (22.7%) 
Hand motions   47 (62.7%)   4 (5.4%) 
Light perception (-)  -  1 (1.3%) 
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  The final visual acuity correlated with the vitreoretinal 
pathology. The greater improvements are seen in the patients 
with vitreous hemorrhage. 
  There were few postoperative complications. Intraopera-
tive and postoperative complications in the combined sur-
gery are shown in Table 2. 
Table 2.  Intraoperative and Postoperative Complications 
 
Complications n  % 
Mild iritis  8  10.7 
Recurrent Vitreous hemorrhage  8  10.7 
Posterior capsule opacification  7  9.3 
Transient increased Intraocular pressure   6  8.0 
Iatrogenic retinal tear  6  8.0 
Postoperative corneal edema   5  6.7 
Epiretinal membrane  3  4.0 
Rubeosis iridis  3  4.0 
Retinal detachment  2  2.7 
Hyphema 2  2.7 
Macular hole  1  1.3 
Phthisis   1  1.3 
 
  Significant recurrent vitreous hemorrhage developed in 8 
eyes (10.7%), 4 eyes (5.3%) required surgical evacuation, 
and 4 eyes (5.3%) cleared spontaneously. Eight eyes (10.7%) 
had a mild iritis but was controlled and resolved with use of 
topical steroids in few days. None of the eyes developed 
anterior chamber fibrin exudation. Posterior capsule opacifi-
cation occurred in 7 eyes (9.3%). Nd:YAG capsulotomy was 
performed in 5 eyes (6.7%) because deterioration in postop-
erative visual acuity. In 6 eyes (8.0%), IOP increased tempo-
rarily for a few days after surgery; all were controlled with 
topical antiglaucomatous medication. Retinal tear occurred 
in 6 eyes during vitrectomy, which was treated by intraop-
erative photocoagulation. Silicone oil was used in these eyes 
after air-fluid exchange. Mild corneal edema developed in 5 
eyes (6.7%), and resolved with using topical steroid and 5% 
NaCl in a few days. Two eyes (2.7%) developed postopera-
tive hyphema; however, none required further surgical 
evacuation and cleared spontaneously. Rhegmatogenous 
retinal detachment developed in 2 eyes (2.7%) postopera-
tively and the retina remained attached after silicone oil in-
jection. 
  Optic atrophy in various degrees was detected in 12 eyes 
(16.0%) postoperatively, and poor visual outcome occurred 
in these eyes. 
  One eye (1.3%) developed phthisis. This eye had in-
cluded severe proliferative diabetic retinopathy, vitreous 
hemorrhage and massive tractional retinal detachment. PPV, 
epiretinal membrane peeling, retina attached with decaline, 
panretinal photocoagulation, and silicon oil injection were 
performed. Hypotony and then phthisis developed postopera-
tively in this eye. 
DISCUSSION 
  Combined cataract extraction and PPV remains contro-
versial. Studies show that many surgeons prefer cataract ex-
traction at the time of PPV even if the cataract is not clini-
cally significant [7]. This is because cataract development in 
the phakic eye after PPV is common. If intraocular tampo-
nade is used in conjunction with PPV, the rate increases; in 
case of silicone oil injection, the rate is reported to be as high 
as 100% [8]. Combined surgery is preferred because of its 
many advantages which are postoperative recovery time is 
shorter, visualization of the posterior pole is good during 
vitrectomy. The technique that combines phacoemulsifica-
tion with PPV through a small limbal incision minimizes 
corneal distortion and gains better visual results [9]. How-
ever, there are possible disadvantages such as difficulty in 
visualizing the capsulorhexis because of an absent or re-
duced red reflex, cataract wound dehiscence caused by globe 
manipulation during vitreous surgery, intraoperative miosis 
after cataract extraction, bleeding from anterior structures, 
loss of corneal transparency from corneal edema, IOL decen-
tration and iris capture in eyes with gas-air or silicone oil 
tamponade, and prismatic effects and undesirable light re-
flexes during vitreoretinal surgery [10]. Careful patient se-
lection is important for the success of combined surgery. 
Phacoemulsification is most easily performed in eyes with 
mild to moderately dense nuclear sclerosis. Harder lenses 
may require excessive ultrasonic energy, much lens manipu-
lation and prolonged irrigation, all of which contribute to 
intraoperative corneal edema [9]. 
  Combined surgery in most cases is safe and allows for 
early visual rehabilitation [11]. In our experience, clear cor-
neal phacoemulsification can be safely combined with PPV. 
The phacoemulsification technique is rapid and does not 
increase operating time significantly. Fundus visualization 
was achieved, especially when working at the retinal periph-
ery. Because the corneal incision is made in avascular tissue, 
there is no bleeding into the anterior chamber and minimal 
postoperative inflammatory reaction [12]. The procedure 
does not interfere with vitreoretinal surgery. The incision is 
resistant to increased intra ocular pressure and globe manipu-
lation during vitreoretinal surgery, even if gas or silicone oil 
injections are performed [12-14]. Scleral depression was also 
used successfully despite the IOL, and small cataract wound 
incision was sutured. Our results indicate that excellent func-
tional visual acuity may be attained by combining PPV with 
phacoemulsification with posterior chamber IOL implanta-
tion. Postoperatively, visual acuity improved in 65 eyes 
(86.7%), was unchanged in 9 eyes (12.0%), and decreased in 
1 eye (1.3%). 0.1 or better visual acuity was achieved in 44 
(69.8%) eyes. Poor postoperative visual acuity (<0.1) was 
attributed to diabetic macular edema, retinal ischemia, or 
optic atrophy. Six eyes (8.0%) experienced an iatrogenic 
break that was successfully repaired during surgery. 
  The choice of IOL material is important when phacoe-
mulsification is combined with vitreoretinal surgery. Be-
cause of the firm adhesion of silicone oil, and the condensa-
tion effects on silicone IOLs, silicone IOLs must be avoided 
in combined operations. Instead, a PMMA or acrylic poly-
mer IOL should be used. In this study, we used acrylic 
polymer IOL in all cases [15]. It is suggested that IOL im-
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pleted or until the gas or silicone oil tamponade is per-
formed. That is why, some surgeons believe that this main-
tains a small self-sealing incision and avoids light reflexes 
and prismatic effects from the IOL that might complicate 
visualization of the posterior pole, especially the most pe-
ripheral retina. However, IOL implantation before vitrec-
tomy may be beneficial. The IOL enables the posterior cap-
sule to be visualized, which reduces the risk for damaging 
the capsule with the vitreous cutter. IOL implantation in the 
presence of vitreous support is less complicated before 
vitrectomy. In addition, the IOL stabilizes the iris-capsule 
diaphragm and prevents posterior capsule bulging when en-
dotamponades are used. Removal of epithelial cells from the 
lens capsule was performed to maintain good intraoperative 
visualization of the most peripheral part of the retina [1,15]. 
In this study, IOL implantation was performed before vitrec-
tomy, and the posterior capsule remained intact in each case 
after surgery. 
  The recognition of true posterior vitreous is clinically 
important. The surgical implications of posterior hyaloid 
removal are obvious. Failure to recognize true posterior vit-
reous hyaloid may contribute to continued morbidity in pa-
tients after vitrectomy. If the residual vitreous cortex on the 
retina is left untreated during vitrecromy, this tissue may 
serve as a scaffold for continued neovascular proliferation, 
and may also contribute to persistent tangential tractional 
force on the retinal surface [5,6,17]. Triamcinolone aceton-
ide is a water-insoluble steroid and has strong anti-
inflamatory and antiangiogenic activity. TA-assisted vitrec-
tomy increases the ability to achieve the anatomic goal of 
removal of cortical vitreous, and may decrease the blood-
ocular break-down after surgery [17,18]. The use of in-
travitreal steroids have possible adverse effects such as glau-
coma. As it has been found in this study, the use of TA en-
ables us to see the residual vitreous cortex clearly and to treat 
it very easily. Therefore, we find this method to be helpful 
and beneficial for surgeons who perform a vitrectomy, espe-
cially for treating vitreoretinal interface abnormalities. In this 
study, In 6 eyes (8.0%), IOP increased temporarily for a few 
days after surgery; all were controlled with topical antiglau-
comatous medication. No significant postoperative inflam-
mation and fibrinous reaction occurred in all patients. Eight 
eyes (10.7%) had a mild iritis but which was controlled and 
resolved with use of topical steroids in a few days. 
  The present study is limited by its retrospective nature, 
non-randomized design, and heterogeneity in diagnoses of 
cases. However, the results of combined phacoemulsifica-
tion, PPV, and IOL implantation show that visual acuity out-
comes are generally favorable and complications are accept-
able. We consider that this is a safe and effective method for 
combined surgery in cases with anterior and posterior seg-
ment pathology. Visual outcomes and complications depend 
primarily on the underlying posterior segment pathology. 
The use of intravitreal TA may simplify surgery especially 
posterior hyaloid removal and decreases the postoperative 
inflammation. 
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